IL17A and rheumatoid arthritis: JNJ-54271074 inhibited IL-17A production from PBMC from RA subjects with IC50 of 5 ± 1.2 nM (Fig. 6C), which was similar to the IC50 typically observed for this compound in PBMC from healthy donors (IC50 = 3 ± 0.9 nM).